Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.2800 (1.8%) ($14.3100 - $15.3500) on Thu. Jul. 18, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.18% (three month average) | RSI | 11 | Latest Price | $15.2800(1.8%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -3.6% a day on average for past five trading days. | Weekly Trend | ATRA declines -9.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(50%) IBB(49%) IWO(48%) ARKK(47%) | Factors Impacting ATRA price | ATRA will decline at least -2.09% in a week (0% probabilities). VIXM(-36%) VXX(-34%) TLT(-13%) UNG(-6%) IFRA(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.09% (StdDev 4.18%) | Hourly BBV | 0 () | Intraday Trend | 2.4% | | | |
|
1 - 5 Day Possible Target | $0.19(-98.76%) | Resistance Level | $18.81 | 5 Day Moving Average | $16.52(-7.51%) | 10 Day Moving Average | $17.54(-12.88%) | 20 Day Moving Average | $18.81(-18.77%) | To recent high | -57.9% | To recent low | 1.8% | Market Cap | $1.135b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |